Naotaka Maruoka Selected Research

Naotaka Maruoka Research Topics

3	Neoplasms (Cancer) 10/2020 - 08/2016
2	Cholangitis 08/2022 - 04/2022
2	Neoplasm Metastasis (Metastasis) 08/2022 - 02/2022
2	Pancreatitis 07/2016 - 01/2015
1	Cysts 04/2024
1	Ascites 04/2024
1	Pleural Effusion (Pleural Effusions) 12/2023
1	Breast Neoplasms (Breast Cancer) 08/2022
1	Pathologic Constriction (Stenosis) 08/2022
1	Liver Diseases (Liver Disease) 08/2022
1	Acute Cholecystitis 04/2022
1	Hemorrhage 04/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2022
1	Hemobilia 02/2022
1	Carcinoma (Carcinomatosis) 02/2022
1	Lymphoma (Lymphomas) 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Autoimmune Pancreatitis 06/2019
1	Type 2 Diabetes Mellitus (MODY) 06/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2019
1	Abscess 03/2017
1	Glucose Intolerance 03/2017
1	Gallstones (Gallstone) 07/2016
1	Hyperamylasemia 07/2016
1	Lemierre Syndrome 03/2015
1	Gastritis 01/2015
1	Fistula 01/2015

2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2019 - 03/2017
1	SteroidsIBA 12/2023
1	Capsules (Microcapsules)IBA 12/2023
1	atezolizumabIBA 08/2022
1	130-nm albumin-bound paclitaxelIBA 08/2022
1	Immune Checkpoint InhibitorsIBA 08/2022
1	B7-H1 AntigenIBA 08/2022
1	Polysorbates (PSML)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	Chromogranin AIBA 10/2020
1	TrypsinIBA 10/2020
1	SynaptophysinIBA 10/2020
1	Immunoglobulin G (IgG)IBA 06/2019
1	Blood Glucose (Blood Sugar)IBA 03/2017
1	Amylases FDA Link 07/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2015
1	Polyglycolic Acid (Polyglycolide)IBA 01/2015

2	Endoscopic Sphincterotomy 04/2022 - 07/2016
2	Stents 04/2022 - 02/2022
1	Punctures 04/2024
1	Therapeutics 12/2023
1	Nephrectomy 02/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Glycemic Control 06/2019
1	Critical Care (Surgical Intensive Care) 03/2017
1	Pancreaticoduodenectomy 08/2016
1	Conservative Treatment 01/2015